Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

about

Effects of blood lipid stability on progression of carotid atherosclerosis.Analysis of traditional and emerging risk factors in premenopausal women with coronary artery disease: A pilot-scale study from North India.

P2860

Q41012566-91798FBA-05C7-4C21-971E-BDDD6CF68E6E Q47817694-F06AE7CC-2F3C-4B08-AAD8-655A8EAB98A4

P2860

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

Item

http://www.wikidata.org/entity/Q36515765

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

@ast

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

@en

type

Item

label

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

@ast

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

@en

prefLabel

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

@ast

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

@en

P1476

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

@en

P2093

Anjali Manocha

http://www.w3.org/2001/XMLSchema#string

L M Srivastava

http://www.w3.org/2001/XMLSchema#string

P2860

Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events

Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.

Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.

Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux.

Genetic architecture and evolution of the lipoprotein(a) trait.

Lipoprotein(a): intrigues and insights.

Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis.

P2888

s12291-015-0483-3

P304

13-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12291-015-0483-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26855483

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

P932

4731365

http://www.w3.org/2001/XMLSchema#string

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

about

P2860

P2860

Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932